Valuation: Divi's Laboratories Limited

Market Cap 2,485B 25.66B 22.91B 21.38B 19.42B 36.54B 36.89B 257B 100B 1,263B 96.34B 94.25B 4,061B P/E 2027 *
76.1x
P/E 2028 * 63x
Enterprise Value 2,450B 25.3B 22.59B 21.07B 19.14B 36.02B 36.38B 253B 98.96B 1,245B 94.98B 92.92B 4,004B EV / Sales 2027 *
19.5x
EV / Sales 2028 * 16.3x
Free-Float
48%
Yield 2027 *
0.38%
Yield 2028 * 0.42%
1 day-0.24%
1 week+1.56%
Current month+0.51%
1 month-1.57%
3 months+37.08%
6 months+56.89%
Current year+46.09%
1 week 9,113.5
Extreme 9113.5
9,660
1 month 8,923
Extreme 8923
9,740
Current year 5,647.5
Extreme 5647.5
9,740
1 year 5,647.5
Extreme 5647.5
9,740
3 years 3,295.3
Extreme 3295.3
9,740
5 years 2,730
Extreme 2730
9,740
10 years 532.65
Extreme 532.65
9,740
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 49 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 49 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap. Importance
3/26/25 A Sell

Executive/Senior Manager

25,000 0.0094%
3/15/25 A Sell 300 0.0001%
2/17/25 A Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.52%+1.56%+52.30%+152.04% 26.31B
-1.61%+1.72%+38.30%+106.93% 1,060B
-0.76%-0.84%+35.21%+62.70% 623B
+0.39%+4.81%+17.81%+83.77% 480B
-0.29%-0.99%+64.79%+37.06% 352B
-2.03%+1.06%+21.08%+42.16% 345B
-1.92%-0.29%+10.54%+33.20% 274B
-2.36%-1.16%-7.14%+8.68% 249B
-1.37%+0.04%+38.29%+52.33% 223B
+0.17%-0.27%+24.40%+96.82% 182B
Average -0.98%+0.74%+29.56%+67.57% 381.43B
Weighted average by Cap. -1.05%+0.76%+30.57%+69.40%

Financials

2027 *2028 *
Net sales 126B 1.3B 1.16B 1.08B 983M 1.85B 1.87B 12.99B 5.08B 63.9B 4.88B 4.77B 206B 150B 1.55B 1.38B 1.29B 1.17B 2.21B 2.23B 15.5B 6.06B 76.25B 5.82B 5.69B 245B
Net income 32.7B 338M 302M 281M 256M 481M 485M 3.38B 1.32B 16.62B 1.27B 1.24B 53.44B 39.53B 408M 365M 340M 309M 581M 587M 4.08B 1.6B 20.09B 1.53B 1.5B 64.61B
Net Debt -34.99B -361M -323M -301M -273M -514M -519M -3.61B -1.41B -17.78B -1.36B -1.33B -57.18B -44.87B -463M -414M -386M -351M -660M -666M -4.63B -1.81B -22.8B -1.74B -1.7B -73.32B
Projected Income Statement - Annual - Divi's Laboratories Limited
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
09/10/26 ₹9,312.00 -0.52% 16,932
08/10/26 ₹9,361.00 -2.37% 441,895
07/10/26 ₹9,588.00 +0.40% 422,217
06/10/26 ₹9,550.00 +3.85% 465,106
05/10/26 ₹9,196.00 -0.57% 480,338
Trader
Investor
Global
Quality
ESG MSCI
BB
Ratings Surperformance© - Divi's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
9,361.00INR
Average target price
8,496.66INR
Spread / Average Target
-9.23%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Divi's Laboratories Limited
  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock